# TMOD1

## Overview
The TMOD1 gene encodes the protein tropomodulin 1, which is a crucial actin-capping protein involved in the regulation of actin filament dynamics. Tropomodulin 1 plays a significant role in maintaining the stability and length of actin filaments by capping their pointed ends, thereby preventing elongation and disassembly. This function is vital for various cellular processes, including cell shape maintenance, motility, and muscle contraction. The protein is particularly important in cardiac muscle, where it influences actin filament architecture and length, impacting myofibrillogenesis and myocardial function. Additionally, tropomodulin 1 is involved in the central nervous system, contributing to dendritic spine morphogenesis and synapse formation. Mutations in the TMOD1 gene have been linked to clinical conditions such as childhood-onset cardiomyopathy and increased cancer susceptibility, underscoring its significance in both cardiac and cancer pathologies (Omotade2018Tropomodulin; Vasilescu2024Recessive; Bliss2014Phosphorylation).

## Structure
Tropomodulin 1 (TMOD1) is a protein that plays a crucial role in capping the pointed ends of actin filaments, thereby regulating their length and stability. The primary structure of TMOD1 includes a sequence of amino acids encoded by the TMOD1 gene. The protein features distinct structural domains, including an N-terminal domain and a C-terminal domain. The N-terminal domain (residues 1-92) is mainly disordered but contains a helical region (residues 24-35) that is part of the tropomyosin (TM) binding domain. This region becomes more ordered upon binding to TM, indicating a coiled-coil motif is required for high-affinity TM binding (Kostyukova2007Molecular; Greenfield2005Structure).

The C-terminal domain of TMOD1 contains leucine-rich repeat motifs and is the major actin-binding domain, capable of capping the pointed end of actin filaments independently of TM (Lewis2014Functional). TMOD1 can form quaternary structures through interactions with TM, with isoform-specific binding preferences (Kostyukova2007Molecular). The protein's structure is characterized by flexibility, particularly in the C-terminal region, which is necessary for its capping activity (Greenfield2005Structure). TMOD1's interaction with TM results in an increase in α-helix structure, suggesting that disordered regions become ordered upon binding (Kostyukova2007Molecular).

## Function
Tropomodulin 1 (TMOD1) is an actin-capping protein that plays a critical role in regulating actin filament dynamics by capping the pointed ends of actin filaments, thereby preventing their elongation and disassembly. This regulation is essential for maintaining the stability and length of actin filaments, which are crucial for cell shape, motility, and muscle contraction (Vasilescu2024Recessive; Bliss2014Phosphorylation). TMOD1 is particularly important in cardiac muscle, where it influences actin filament architecture and length, impacting myofibrillogenesis and myocardial function (Bliss2014Phosphorylation).

In cardiac myocytes, TMOD1's phosphorylation at threonine 54 (Thr54) by TRPM7 kinase modulates its ability to cap actin filaments, affecting thin filament assembly and length regulation (Bliss2014Phosphorylation). This phosphorylation does not alter its tropomyosin-binding activity, indicating a specific regulatory mechanism for actin filament dynamics (Bliss2014Phosphorylation). TMOD1 is also involved in the central nervous system, where it contributes to dendritic spine morphogenesis and synapse formation, highlighting its role in neuronal development and synaptic function (Omotade2018Tropomodulin). Overall, TMOD1 is vital for maintaining proper actin filament length and stability, which is essential for normal cellular and organismal function.

## Clinical Significance
Mutations in the TMOD1 gene, particularly the recessive p.R189W variant, are associated with childhood-onset cardiomyopathy, including both dilated and restrictive forms. This mutation affects the protein's ability to regulate actin filament dynamics, leading to impaired capping of actin filament pointed ends and resulting in altered thin filament lengths. These changes contribute to the weakening of the heart muscle, a hallmark of cardiomyopathy (Vasilescu2024Recessive).

The p.R189W mutation does not disrupt the sarcomere structure but impairs TMOD1's interaction with actin, weakening its capping ability. This leads to pathological changes in thin filament lengths, which are crucial for proper cardiac function (Vasilescu2024Recessive). The mutation has been identified in patients from two unrelated families, suggesting a potential ancient founder effect (Vasilescu2024Recessive).

In addition to cardiomyopathy, TMOD1 polymorphisms have been linked to an increased risk of thyroid carcinoma in the Chinese Han population. Specific single nucleotide polymorphisms (SNPs) in TMOD1 are associated with cancer susceptibility, potentially through alterations in protein structure and function or gene expression (Tong2022Suggestive). These findings highlight the clinical significance of TMOD1 in both cardiac and cancer pathologies.

## Interactions
Tropomodulin 1 (TMOD1) is known for its interactions with actin and tropomyosin (TM), playing a crucial role in regulating actin filament dynamics. TMOD1 contains two actin-binding sites: a TM-dependent site located at residues 48-92 and a TM-independent site in the C-terminal domain (residues 323-359). The TM-dependent site involves an amphipathic helix that facilitates Tmod-actin binding, while the TM-independent site is essential for actin capping in the absence of TM (Colpan2013Tropomodulins; Kostyukova2008TropomodulinTropomyosin).

TMOD1 also has two TM-binding sites, located within residues 1-38 and 109-144. These sites are crucial for its interaction with various TM isoforms, which significantly enhance TMOD1's affinity for actin and its capping activity (Kostyukova2006Tropomodulin; Kostyukova2008TropomodulinTropomyosin). Mutations in these binding sites, such as L27G and I131D, can disrupt TM binding and reduce actin polymerization inhibition (Kostyukova2006Tropomodulin; Lewis2014Functional).

The interaction between TMOD1 and TM is isoform-specific, with TMOD1 showing a preference for certain TM isoforms, such as those from erythrocytes. This specificity is influenced by the N-terminal sequences of TM (Kostyukova2008TropomodulinTropomyosin). TMOD1's ability to bind two TM molecules simultaneously suggests a cooperative mechanism in actin filament capping (Kostyukova2006Tropomodulin).


## References


[1. (Kostyukova2008TropomodulinTropomyosin) Alla S. Kostyukova. Tropomodulin/Tropomyosin Interactions Regulate Actin Pointed End Dynamics, pages 283–292. Springer New York, 2008. URL: http://dx.doi.org/10.1007/978-0-387-85766-4_21, doi:10.1007/978-0-387-85766-4_21. This article has 18 citations.](https://doi.org/10.1007/978-0-387-85766-4_21)

[2. (Kostyukova2007Molecular) Alla S. Kostyukova, Sarah E. Hitchcock-DeGregori, and Norma J. Greenfield. Molecular basis of tropomyosin binding to tropomodulin, an actin-capping protein. Journal of Molecular Biology, 372(3):608–618, September 2007. URL: http://dx.doi.org/10.1016/j.jmb.2007.05.084, doi:10.1016/j.jmb.2007.05.084. This article has 49 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2007.05.084)

[3. (Lewis2014Functional) Raymond A. Lewis, Sawako Yamashiro, David S. Gokhin, and Velia M. Fowler. Functional effects of mutations in the tropomyosin‐binding sites of tropomodulin1 and tropomodulin3. Cytoskeleton, 71(7):395–411, July 2014. URL: http://dx.doi.org/10.1002/cm.21179, doi:10.1002/cm.21179. This article has 11 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/cm.21179)

[4. (Tong2022Suggestive) Kaijun Tong, Chang Zhang, Tingting Yang, Rongbiao Guo, Xinyuan Wang, Renyang Guan, and Tianbo Jin. Suggestive evidence of the genetic association of tmod1 and ptcsc2 polymorphisms with thyroid carcinoma in the chinese han population. BMC Endocrine Disorders, October 2022. URL: http://dx.doi.org/10.1186/s12902-022-01177-2, doi:10.1186/s12902-022-01177-2. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12902-022-01177-2)

[5. (Bliss2014Phosphorylation) Katherine T. Bliss, Takehiro Tsukada, Stefanie Mares Novak, Maxim V. Dorovkov, Samar P. Shah, Chinedu Nworu, Alla S. Kostyukova, and Carol C. Gregorio. Phosphorylation of tropomodulin1 contributes to the regulation of actin filament architecture in cardiac muscle. The FASEB Journal, 28(9):3987–3995, June 2014. URL: http://dx.doi.org/10.1096/fj.13-246009, doi:10.1096/fj.13-246009. This article has 9 citations.](https://doi.org/10.1096/fj.13-246009)

[6. (Omotade2018Tropomodulin) Omotola F. Omotade, Yanfang Rui, Wenliang Lei, Kuai Yu, H. Criss Hartzell, Velia M. Fowler, and James Q. Zheng. Tropomodulin isoform-specific regulation of dendrite development and synapse formation. The Journal of Neuroscience, 38(48):10271–10285, October 2018. URL: http://dx.doi.org/10.1523/JNEUROSCI.3325-17.2018, doi:10.1523/jneurosci.3325-17.2018. This article has 33 citations.](https://doi.org/10.1523/JNEUROSCI.3325-17.2018)

[7. (Vasilescu2024Recessive) Catalina Vasilescu, Mert Colpan, Tiina H. Ojala, Tuula Manninen, Aino Mutka, Kaisa Ylänen, Otto Rahkonen, Tuija Poutanen, Laura Martelius, Reena Kumari, Helena Hinterding, Virginia Brilhante, Simo Ojanen, Pekka Lappalainen, Juha Koskenvuo, Christopher J. Carroll, Velia M. Fowler, Carol C. Gregorio, and Anu Suomalainen. Recessive tmod1 mutation causes childhood cardiomyopathy. Communications Biology, January 2024. URL: http://dx.doi.org/10.1038/s42003-023-05670-9, doi:10.1038/s42003-023-05670-9. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s42003-023-05670-9)

[8. (Kostyukova2006Tropomodulin) Alla S. Kostyukova, Andy Choy, and Brian A. Rapp. Tropomodulin binds two tropomyosins: a novel model for actin filament capping. Biochemistry, 45(39):12068–12075, September 2006. URL: http://dx.doi.org/10.1021/bi060899i, doi:10.1021/bi060899i. This article has 59 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/bi060899i)

[9. (Colpan2013Tropomodulins) Mert Colpan, Natalia A. Moroz, and Alla S. Kostyukova. Tropomodulins and tropomyosins: working as a team. Journal of Muscle Research and Cell Motility, 34(3–4):247–260, July 2013. URL: http://dx.doi.org/10.1007/s10974-013-9349-6, doi:10.1007/s10974-013-9349-6. This article has 32 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s10974-013-9349-6)

[10. (Greenfield2005Structure) Norma J. Greenfield, Alla S. Kostyukova, and Sarah E. Hitchcock-DeGregori. Structure and tropomyosin binding properties of the n-terminal capping domain of tropomodulin 1. Biophysical Journal, 88(1):372–383, January 2005. URL: http://dx.doi.org/10.1529/BIOPHYSJ.104.051128, doi:10.1529/biophysj.104.051128. This article has 75 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1529/BIOPHYSJ.104.051128)